3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
34
Squamous Cell Carcinoma of Head and Neck
22
Uterine Cervical Neoplasms
19
Lung Neoplasms
19
Small Cell Lung Carcinoma
16
Oropharyngeal Neoplasms
14
Ovarian Neoplasms
12
Carcinoma
10
Urinary Bladder Neoplasms
9
Stomach Neoplasms
9
Mouth Neoplasms
9
Laryngeal Neoplasms
9
Fallopian Tube Neoplasms
9
Hypopharyngeal Neoplasms
8
Mesothelioma, Malignant
7
Medulloblastoma
7
Cholangiocarcinoma
7
Breast Neoplasms
7
Adenocarcinoma of Lung
7
Pancreatic Neoplasms
6
Neuroblastoma
6
Nasopharyngeal Carcinoma
6
Gallbladder Neoplasms
6
Ganglioneuroblastoma
5
Brain Neoplasms
5
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Lymphoid Interstitial Pneumonia
4
Head and Neck Neoplasms
4
Esophageal Neoplasms
4
Interventions
pembrolizumab
4
Pemetrexed
4
Carboplatin
4
Gemcitabine
3
Bevacizumab
3
tusamitamab ravtansine
2
Vinorelbine
2
Ramucirumab
2
Erlotinib Hydrochloride
2
Docetaxel
2
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
2
vistusertib
1
vandetanib
1
telomerase reverse transcriptase p572Y, human
1
spartalizumab
1
sotorasib
1
sintilimab
1
olaparib
1
necitumumab
1
icotinib
1
durvalumab
1
dacomitinib
1
capivasertib
1
aumolertinib
1
Radiosurgery
1
Platinum
1
Paclitaxel
1
MLN 8237
1
LY3023414
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Non-small Cell Lung Cancer Metastatic
×
Platinum
×
Clear all
NCT05407155
2026-04-23
BETTER
Fudan University
Phase NA
Active not recruiting
56 enrolled